Regulatory Strategy and Global Filings
Regulatory Strategy
Our experienced consultants help clients design regulatory strategies that can trim months and dollars off product development paths. We are adept at mapping our clients’ business strategy, risk tolerance, and budget to the proper regulatory path. Pearl Pathways can also design a logical and clever global registration plan that allows you to maximize re-use of critical clinical, non-clinical, CMC, and product engineering and testing data globally.
Global Filings
We expertly negotiate interactions and filings with global health authorities so that pharmaceutical and biologics, diagnostics, and devices are on the market as quickly as possible. Our team has broad expertise across the entire spectrum of regulatory requirements including clinical, non-clinical, CMC, Design Controls, 21 CFR Part 11, and the nuances of companion diagnostics. Our team also has the expertise to format, compile, publish, and submit your bio-pharmaceutical regulatory submission electronically through FDA’s Electronic Submissions Gateway (ESG) using the eCTD format. Additionally, we are adept at the required eCopy format for 510k and PMA medical devices.
Types of filings:
- IND, NDA, ANDA, IMPD, CTA, MAA
- BLA, HUD, HDE
- Drug Master File (eDMF)
- 505 (b)(2), ANDA
- IDE, CE Mark, 510k, PMA
- US FDA tobacco submissions for both Premarket Tobacco Application (PMTA) and Modified Risk Tobacco Product (MRTP)
- Orphan drug and device designation
- Fast track designations
- Expanded Access/Compassionate Use
- Certificates of Origin
Can’t find what you’re looking for or have questions? Give us a call.